Announcements Trials
Browse Landscape

Status

Completed 30Terminated 5Withdrawn 2Unknown 2Recruiting 2Not yet recruiting 1No longer available 1

Sponsor Class

INDUSTRY 1

Study Type

Expanded_access 1

Sponsor

Cancer Type

Plasma cell 1Lymphoid 1

Conditions

Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Hodgkin Disease 1

Interventions

elotuzumab 4Lenalidomide 3Dexamethasone 3Bortezomib 3Panobinostat 2ulocuplumab 1talquetamab 1selinexor 1pomalidomide 1plerixafor 1fludarabine phosphate 1ceritinib 1carfilzomib 1Whole-Body Irradiation 1Tacrolimus 1Prednisone 1Mycophenolic Acid 1Melphalan 1Cytarabine 1Crizotinib 1Cord Blood Stem Cell Transplantation 1Calcium Dobesilate 1Busulfan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
No longer available × plerixafor × Plasma cell × Clear all
NCT00720603 2015-03-24

EAP

Sanofi

No longer available
LymphoidPlasma cell

Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡